Clinical Trial: Study of Telaprevir in Subjects With Hepatic Impairment

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title:

Brief Summary: The purpose of this study is to assess the safety and pharmacokinetics of Telaprevir following administration of multiple oral doses to subjects with moderate and severe hepatic impairment.

Detailed Summary:
Sponsor: Vertex Pharmaceuticals Incorporated

Current Primary Outcome: Pharmacokinetics

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Vertex Pharmaceuticals Incorporated

Dates:
Date Received: July 30, 2007
Date Started: September 2007
Date Completion:
Last Updated: October 28, 2008
Last Verified: October 2008